Paper - WANFANG MED ONLINE

You Position: Home > Paper

Endeavor to improve the outcome of liver transplantation for hepatocellular carcinoma:Selection criteria of recipient and perioperative adjuvant therapy in liver transplantation for hepatocellular carcinoma

( views:279, downloads:156 )

Author:: No author available

Journal Title:: CHINESE JOURNAL OF ORGAN TRANSPLANTATION

Issue:: 6

DOI:: 10.3760/cma.j.issn.0254-1785.2011.06.001

Key Word:: No keyword available

Abstract： @@ 肝细胞癌(以下简称"肝癌")是严重威胁人类健康的恶性肿瘤,全球每年新发肝癌约626 000例,因肝癌死亡598 000例.我国是肝癌高发地区,每年新发肝癌约344 000例,约占全球新发病例的55 %,在我国恶性肿瘤所致死亡中,肝癌是第2大死亡原因[1].

Reference

[1]严律南.肝癌肝移植的现状与展望[J].2005,(4).
[2]董家鸿.重塑肝细胞癌的系统化治疗模式[J].2007,(1).
[3]陈规划,陆敏强,蔡常洁,等.肝癌肝移植术后个体化化疗疗效初步分析[J].2004,(17).
[4]董家鸿.肝细胞癌治疗理念与策略的转变[J].2009,(2).
[5]樊嘉,周俭,徐泱,等.肝癌肝移植适应证的选择：上海复旦标准[J].2006,(18).
[6]O\u02bcGRADY JOHN G.,POLSON REX J.,ROLLES KEITH,etc.Liver Transplantation for Malignant Disease[J].1988.
[7]Hirose R,Roberts JP,Terrault N,etc.Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis.[J].2008,48(3).
[8]Mariani L,Majno P,Bruix J,etc.Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis.[J].2009,10(1).
[9]Bacchetti P,Ascher NL,Roberts JP,etc.Liver transplantation for hepatocellular carcinoma: Comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria.[J].2002,8(9).
[10]Lee SG,Kim DG,Hwang S,etc.Liver transplantation for adult patients with hepatocellular carcinoma in Korea: comparison between cadaveric donor and living donor liver transplantations.[J].2005,11(10).
[11]Herber S,Heise M,Bittinger F,etc.Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma.[J].2006,12(8).
[12]Belghiti J,Greig PD,Carr BI,etc.Treatment before liver transplantation for HCC.[J].2008,15(4).
[13]Kenison J,Lo CM,Trotter JF,etc.Documented deaths of hepatic lobe donors for living donor liver transplantation.[J].2006,12(10).
[14]Llovet JM,Schwartz M,Mazzaferro V.Resection and liver transplantation for hepatocellular carcinoma.[J].2005,25(2).
[15]Satoru, Todo,Hiroyuki, Furukawa.Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan.[J].2004,240(3).
[16]S, Iwatsuki,T E, Starzl,D G, Sheahan,etc.Hepatic resection versus transplantation for hepatocellular carcinoma.[J].1991,214(3).
[17]Pisani P,Ferlay J,Parkin DM,etc.Global cancer statistics, 2002.[J].2005,55(2).
[18]Llovet JM,Ricci S,Mazzaferro V,etc.Sorafenib in advanced hepatocellular carcinoma.[J].2008,359(4).
[19]Makuuchi M,Sano K.The surgical approach to HCC: our progress and results in Japan.[J].2004,10(2 Suppl.1).
[20]V, Mazzaferro,E, Regalia,R, Doci,etc.Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.[J].1996,334(11).